genital herpes

Search with Google Search with Bing
Information
Disease name
genital herpes
Disease ID
DOID:8704
Description
"A herpes simplex that results_in infection located_in genital system, or located_in rectum, has_material_basis_in Human herpesvirus 1 or has_material_basis_in Human herpesvirus 2, which is transmitted_by sexual contact. The infection has_symptom sores, has_symptom fever, and has_symptom swollen glands." [url:http\://www.cdc.gov/std/herpes/stdfact-herpes.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06033261 Active, not recruiting Phase 1/Phase 2 A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes September 6, 2023 June 4, 2025
NCT00129818 Completed Phase 4 A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding July 2004 October 2005
NCT00231049 Completed Phase 1 Trial Evaluating Safety, Tolerability and Immune Response of AG-707 March 2006
NCT00262106 Completed Phase 3 Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection October 2005 September 2009
NCT00306787 Completed Phase 3 Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes March 2006 February 2008
NCT00362297 Completed Phase 4 Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 September 2006 September 2011
NCT00477334 Completed Phase 4 Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients June 2007 March 2009
NCT00495573 Completed HSV-2 Shedding Resolution After Acyclovir Treatment June 2007 March 2012
NCT00527618 Completed Phase 4 Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV December 2007 March 2011
NCT00723229 Completed Phase 4 A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation August 2008 September 2011
NCT00808405 Completed N/A GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women January 2009 July 2010
NCT01112956 Completed Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2 July 2009 February 2011
NCT01132716 Completed N/A Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions September 2006 September 2006
NCT01132729 Completed N/A Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions September 2006 September 2006
NCT01281007 Completed Phase 3 Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes July 2012 March 2015
NCT01346475 Completed Phase 4 Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 November 2008 September 2011
NCT01390805 Completed Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis) November 2006 March 2011
NCT03080961 Completed N/A The VIBLOK SAfety and perFormancE Trial March 27, 2017 November 13, 2017
NCT03831165 Completed Phase 4 Melatonin Effects on Genital Herpes in Brazilian Women September 2, 2015 December 28, 2021
NCT05500053 Completed A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease August 3, 2022 December 31, 2022
NCT03595995 Not yet recruiting Phase 2 A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 June 1, 2023 June 30, 2024
NCT05675228 Recruiting Knowledge of Young Adults About Genital Herpes December 2, 2022 July 1, 2023
NCT01765114 Terminated Phase 2 A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes February 2013 August 2014
NCT03146403 Terminated Phase 2 Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection May 24, 2017 June 11, 2018
NCT00495716 Terminated Phase 4 Effect of HSV-2 Suppressive Therapy on Sexual Behavior January 2008 June 2010
NCT04222985 Terminated Phase 1 Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2 February 18, 2020 May 19, 2021
NCT01658826 Terminated Phase 2 Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes October 2012 July 2013
NCT00124878 Unknown status Phase 3 Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community August 2003 September 2009
Disase is a (Disease Ontology)
DOID:8566
Cross Reference ID (Disease Ontology)
ICD9CM:054.1
Cross Reference ID (Disease Ontology)
MESH:D006558
Cross Reference ID (Disease Ontology)
NCI:C14364
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154333002
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0019342
Exact Synonym (Disease Ontology)
Genital herpes simplex
Exact Synonym (Disease Ontology)
Herpes Genitalis
Exact Synonym (Disease Ontology)
venereal herpes
Exact Synonym (Disease Ontology)
Virus-Genital Herpes